In the News / Meet With Us / Press Releases

Press Releases

CiceroDx announces launch of ReceptivaDx for Unexplained Infertility & Detection of Endometriosis

Meet With Us

March 9, 2019 – Gateway to Parenthood – Ameristar Resort & Casino, St. Louis Metro Area, MO –

April 3 – 7, 2019 – Pacific Coast Reproductive Society – Indian Wells, CA –

June 5 – 8, 2019 – Midwest Reproductive Symposium International – Chicago, IL –

October 12 – 16, 2019 – CiceroDx to exhibit at American Society of Reproductive Medicine (ASRM) – Philadelphia, PA –

Apr 23, 2018 Focus On Fertility Talks ReceptivaDx

Oct 15, 2018 ReceptivaDx at the ASRM Expo

The ReceptivaDxTM Test was developed by CiceroDx in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.

Copyright © 2020 ReceptivaDx™ | All Rights Reserved